Few surgeons in America have changed the future of medicine as dramatically as Robert Montgomery. A world-renowned transplant surgeon, medical innovator, and chairman of surgery at NYU Langone Health, Dr. Montgomery has spent his career solving one of healthcare’s most urgent problems: the severe shortage of donor organs.
His work has helped redefine what is possible in transplant medicine.
Dr. Montgomery serves as Chair of the Department of Surgery at NYU Langone Health, Professor at NYU Grossman School of Medicine, and Director of the NYU Langone Transplant Institute. Over the course of his career, he has pioneered major improvements in kidney transplantation, including laparoscopic live-donor nephrectomy, long-distance kidney shipping, desensitization strategies, and paired kidney donation programs that have helped hundreds of patients receive life-saving transplants.
His leadership in transplantation is deeply personal. In 2018, Dr. Montgomery himself received a heart transplant using a hepatitis C-positive donor organ—an example of the same innovative thinking he has long advocated for in transplant medicine.
But his most groundbreaking work came through xenotransplantation—the transplantation of organs from animals into humans.
In 2021, Dr. Montgomery led the first successful transplantation of a genetically modified pig kidney into a human recipient at NYU Langone Health. The procedure, performed on a brain-dead patient, showed no immediate signs of rejection and marked a historic breakthrough in medicine. It was one of the clearest demonstrations yet that genetically engineered animal organs could help solve the global organ shortage crisis.
His work continued to push forward. In late 2025, Dr. Montgomery was a lead author on major Nature research examining the physiology and immunology of pig-to-human kidney xenotransplantation, helping establish stronger scientific foundations for future clinical applications. This research is critical because it moves xenotransplantation from experimental headlines toward real-world patient care.
TIME recognized Dr. Montgomery among the most influential people of 2025, and the American College of Surgeons highlighted his contributions not only to transplant innovation but also to humanitarian medical work, including efforts supporting patients in war-affected regions such as Ukraine. He also received the 2024 ACS Jacobson Innovation Award.
What separates Dr. Montgomery from many surgical leaders is that his work is not focused on improving margins—it is focused on eliminating waiting lists. Thousands of Americans die each year waiting for donor organs. His vision is that xenotransplantation could make organ supply renewable rather than limited by human donation alone.
He once compared the current transplant system to an economy dependent on fossil fuels: necessary, but fundamentally insufficient. Xenotransplantation, in his view, represents the renewable energy future of transplant medicine.
For MoversAndShakers.io, Dr. Robert Montgomery is the definition of transformational leadership. He is not simply improving surgery—he is challenging the biological limits of modern medicine itself.
His work may ultimately create a future where no patient dies waiting for an organ donor.
That is not just innovation. That is history.
